Author:
Guo Qian,Gao Jian,Guo Hui,Xie Jun,Cheng Jingmin
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference37 articles.
1. Towards the era of immune checkpoint inhibitors and personalized cancer immunotherapy;Nakajima;Immunol. Med.,2021
2. J.R. Brahmer, C. Lacchetti, B.J. Schneider, M.B. Atkins, K.J. Brassil, J.M. Caterino, I. Chau, M.S. Ernstoff, J.M. Gardner, P. Ginex, S. Hallmeyer, J. Holter Chakrabarty, N.B. Leighl, J.S. Mammen, D.F. McDermott, A. Naing, L.J. Nastoupil, T. Phillips, L.D. Porter, I. Puzanov, C.A. Reichner, B.D. Santomasso, C. Seigel, A. Spira, M.E. Suarez-Almazor, Y. Wang, J.S. Weber, J.D. Wolchok, J.A. Thompson, N. National Comprehensive Cancer, Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline, J. Clin. Oncol. 36(17) (2018) 1714-1768.
3. Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis;Wang;JAMAOncol,2018
4. Hematologic Complications of Immune Checkpoint Inhibitors;Davis;Oncologist,2019
5. New insights into the pathophysiology of acquired cytopenias;Young;Hematology Am. Soc. Hematol. Educ. Program,2000
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献